Valuation: Electromed, Inc.

Market Cap 236M 208M 197M 178M 335M 22.61B 338M 2.36B 910M 11.55B 885M 866M 37.16B P/E 2027 *
19.4x
P/E 2028 * 16.7x
Enterprise Value 236M 208M 197M 178M 335M 22.61B 338M 2.36B 910M 11.55B 885M 866M 37.16B EV / Sales 2027 *
2.83x
EV / Sales 2028 * 2.56x
Free-Float
82.99%
Yield 2027 *
-
Yield 2028 * -
1 day-1.54%
1 week+0.65%
Current month-0.79%
1 month-0.79%
3 months-34.29%
6 months+14.01%
Current year-4.70%
1 week 27.12
Extreme 27.12
28.27
1 month 25.81
Extreme 25.81
29.9
Current year 23.01
Extreme 23.01
47.4
1 year 23.01
Extreme 23.01
47.4
3 years 9.53
Extreme 9.53
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.38
Extreme 3.38
47.4
Manager TitleAgeSince
Chief Executive Officer 61 01/07/2023
Director of Finance/CFO 44 14/11/2022
Compliance Officer - 01/09/2023
Director TitleAgeSince
Chairman 69 01/07/2023
Director/Board Member 76 21/11/2014
Director/Board Member 57 15/08/2019
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Free

Chief Financial Officer

15,602 0.1865%
1/9/26 Tax

Chief Executive Officer

-2,671 0.0319%
30/6/26 Tax

Chief Financial Officer

-674 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%+0.65%+13.08%+167.08% 236M
+0.03%+2.80%+46.52%+33.74% 251B
-0.81%+1.84%+21.02%-9.24% 160B
-0.81%+2.31%-6.34%+40.74% 147B
-1.58%-3.19%-55.19%-17.64% 63.93B
+1.19%-1.03%+13.83%+26.83% 50.05B
-0.16%+4.56%+41.32%+56.39% 49.4B
-0.05%+3.26%-15.24%-19.48% 48.94B
-0.20%+3.65%+52.46%+60.92% 43.52B
+0.39%+9.81%+195.77%+97.93% 41.06B
Average -0.38%+4.33%+30.72%+43.73% 85.44B
Weighted average by Cap. -0.34%+4.07%+26.78%+25.42%

Financials

2027 *2028 *
Net sales 83.15M 73.38M 69.43M 62.96M 118M 7.98B 119M 833M 321M 4.07B 312M 305M 13.11B 92.05M 81.23M 76.86M 69.7M 131M 8.83B 132M 922M 355M 4.51B 346M 338M 14.51B
Net income 12.6M 11.12M 10.52M 9.54M 17.89M 1.21B 18.06M 126M 48.64M 617M 47.31M 46.28M 1.99B 14.75M 13.02M 12.32M 11.17M 20.94M 1.42B 21.15M 148M 56.94M 723M 55.39M 54.18M 2.33B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
196
Date Price Change Volume
30/09/26 US$27.79 -1.37% 59,869
28/09/26 US$28.17 +1.04% 87,810
25/09/26 US$27.88 +0.07% 92,768
24/09/26 US$27.86 +1.05% 64,689
23/09/26 US$27.57 0.00% 71,817
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
28.17USD
Average target price
48.50USD
Spread / Average Target
+72.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock